Page last updated: 2024-08-25

honokiol and Esophageal Neoplasms

honokiol has been researched along with Esophageal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajani, JA; Chen, G; Demizu, Y; Guha, S; Huang, P; Hung, MC; Izzo, J; Wang, F; Wu, X1
Arbiser, JL; Cheng, E; Huo, X; Souza, RF; Spechler, SJ; Wang, DH; Yu, C; Zhang, HY; Zhang, Q; Zhang, X1

Other Studies

2 other study(ies) available for honokiol and Esophageal Neoplasms

ArticleYear
Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol.
    Antioxidants & redox signaling, 2009, Volume: 11, Issue:5

    Topics: Adenocarcinoma; Base Sequence; Bile Acids and Salts; Biphenyl Compounds; Cell Line, Transformed; Cyclophilins; Epithelial Cells; Esophageal Neoplasms; Esophagus; Humans; Lignans; Oxidation-Reduction; Peptidyl-Prolyl Isomerase F; RNA, Small Interfering

2009
Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells.
    American journal of physiology. Gastrointestinal and liver physiology, 2012, Sep-01, Volume: 303, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Barrett Esophagus; Biphenyl Compounds; Cell Line, Tumor; Cell Transformation, Neoplastic; Esophageal Neoplasms; Humans; Lignans; Signal Transduction; STAT3 Transcription Factor

2012